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ABSTRACT
Background The homogeneous genotype and
stereotyped phenotype of a unique familial form of
amyotrophic lateral sclerosis (ALS) (patients homozygous
for aspartate-to-alanine mutations in codon 90
(homD90A) superoxide dismutase 1) provides an ideal
model for studying genotype/phenotype interactions and
pathological features compared with heterogeneous
apparently sporadic ALS. The authors aimed to use
diffusion tensor tractography to quantify and compare
changes in the intracerebral corticospinal tracts of
patients with both forms of ALS, building on previous
work using whole-brain voxelwise group analysis.
Method 21 sporadic ALS patients, seven homD90A
patients and 20 healthy controls underwent 1.5 T
diffusion tensor MRI. Patients were assessed using
‘upper motor neuron burden,’ El Escorial and ALSFR-R
scales. The intracranial corticospinal tract was assessed
using diffusion tensor tractography measures of
fractional anisotropy (FA), mean diffusivity, and radial
and axial diffusivity obtained from its entire length.
Results Corticospinal tract FA was reduced in sporadic
ALS patients compared with both homD90A ALS
patients and controls. The diffusion measures in sporadic
ALS patients were consistent with anterograde
(Wallerian) degeneration of the corticospinal tracts. In
sporadic ALS, corticospinal tract FA was related to
clinical measures. Despite a similar degree of clinical
upper motor neuron dysfunction and disability in
homD90A ALS patients compared with sporadic ALS,
there were no abnormalities in corticospinal tract
diffusion measures compared with controls.
Conclusions Diffusion tensor tractography has shown
axonal degeneration within the intracerebral portion of
the corticospinal tract in sporadic ALS patients, but not
those with a homogeneous form of familial ALS. This
suggests significant genotypic influences on the
phenotype of ALS and may provide clues to slower
progression of disease in homD90A patients.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a complex
progressive neurodegenerative disease affecting
upper (UMN) and lower (LMN) motor neurons of
the motor cortex, brainstem and spinal cord.1 An
estimated 90% of ALS cases are apparently
sporadic. Clinical manifestations include muscle
weakness, wasting and spasticity, resulting in death
2e5 years after onset. The remaining 10% of ALS
cases are understood to be familial, with 20% of
these being closely associated with over 100
predominantly missense genetic mutations2 in
a gene that codes for cytosolic Cu/Zn binding
superoxide dismutase (SOD-1) on chromosome 21.3
SOD-1 mutations are typically inherited in a domi-
nant fashion, but recessive patterns of inheritance
have been shown in patients homozygous for
aspartate-to-alanine mutations in codon 90
(homD90A), representing the most common
SOD-1 mutation.4 Although homD90A patients
have a disease phenotype similar to sporadic ALS
(see Weber et al5 for a review), they have a longer
mean survival (mean 12.6 years vs 4 years), the
reason for which is unknown.
Imaging techniques such as diffusion tensor MRI
(DTI) have been used to quantify corticospinal
tract degeneration in vivo in sporadic ALS
patients.6e8 DTI can be used to estimate organisa-
tional properties of tissue microstructure and
orientation of white-matter ﬁbre tracts based on
the principles of water displacement.9 Diffusion of
water molecules is higher parallel to ﬁbre bundles
than perpendicular to them, creating a directional
bias, which can be detected using DTI.10 Four
principal outcome measures can be computed:
fractional anisotropy (FA), a measure of direction-
ality of diffusion, mean diffusivity (MD), a measure
of overall diffusion of water in a voxel, axial
diffusivity, which reﬂects diffusion along ﬁbre
bundles, and radial diffusivity, which reﬂects
diffusion perpendicular to ﬁbre bundles. By deter-
mining the relationship of diffusion information
between adjacent voxels, detailed 3-D images of
ﬁbre tracts can be constructed (tractography) for
quantitative analysis.11
The corticospinal tracts (CSTs) contain the major
efferent UMN ﬁbre projection connecting the
motor cortex with the brainstem and spinal cord.12
Projections from UMN, originating in the motor
cortex, converge in the corona radiata, descend
through the posterior limb of the internal capsule
and continue into the cerebral peduncles and pons
before entering the spinal cord.13 By placing regions
of interest (ROI) at several of these known
anatomical locations, it is possible to delineate the
CSTs and quantify UMN degeneration throughout
their entire intracerebral length as reﬂected by
abnormal diffusion values.
Previously, we have demonstrated differences
between sALS, homD90A and controls using
whole-brain voxelwise group analysis of FA.14 The
current study used a different and newer analysis
technique, diffusion tensor tractography to
examine diffusion characteristics along the
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intracerebral corticospinal tract in the same cohort of patients
with sporadic ALS and those homozygous for the D90A SOD-1
mutation. Using diffusion tensor tractography one can deter-
mine axial and radial diffusivity which cannot be measured
using whole-brain voxelwise analysis approaches and provide
information, which we hoped would allow us to understand
better the pathophysiology of ALS in vivo. It was hypothesised
that CST damage would be more pronounced in both ALS
groups compared with age-matched healthy controls, but less
extensively in homD90A compared with sporadic ALS
patients. This is in line with previous comparative studies
showing relatively preserved cortical inhibition,15 and more
frontally dominant patterns of reduced cortical binding of
[11C]-ﬂumazenil,15 and volumetric cortical loss16 in homD90A
ALS. In addition, we hypothesised that diffusion tensor trac-
tography measures might correlate with clinical measures of
disease severity, UMN pathology and disease duration.
METHOD
Subjects
Twenty-one patients with sporadic ALS (six female), seven with
homozygous D90A SOD-1 ALS (six female) and 20 healthy
control subjects (eight female) took part in the study. All but
one of the subjects was right-handed, with no previous history
of cerebrovascular disease, diabetes mellitus or hypertension.
Patients with sporadic ALS were recruited from the King’s
Motor Neuron Disease Care and Research Centre, London, and
diagnosed following clinical examination by a consultant
neurologist. Other disorders were excluded by appropriate blood
tests, neurophysiology and neuroimaging.1 Patients with
sporadic ALS were classiﬁed according to the revised El Escorial
criteria17 as four ‘deﬁnite,’ eight ‘probable’ and eight ‘possible.’
HomD90A ALS patients were recruited from Umeå University
Hospital, Umeå, Sweden and travelled to London to take part in
the study. Healthy volunteers with no history of neurological
symptoms were recruited from the spouses and family members
of patients and from members of local voluntary organisations.
The study was approved by the King’s College London, Institute
of Psychiatry local research ethics committee and conformed
to the standards set by the 1964 Declaration of Helsinki.
Written, informed consent was given by all subjects prior to
participation in the study.
Clinical evaluation
Clinical evaluations were performed on the day of MRI scan-
ning. Disease duration was calculated for all patients in months
from the time of onset. Patients were assessed by a neurologist
(VW) using standardised disease rating scales. Global disease
severity was assessed using the revised ALS functional rating
scale (ALSFRS-R).18 The Ashworth Spasticity Scale19 was used
in all patients to provide a speciﬁc measure of UMN dysfunc-
tion. In addition, patients underwent a more detailed assessment
of UMN ‘burden’ by totalling the number of pathological UMN
signs on examination.20 These were taken as subjectively
pathologically brisk facial and jaw jerks; biceps, triceps,
brachioradialis, knee and ankle reﬂexes; Hoffman’s sign; and
extensor plantar responses (all scored bilaterally) giving
a maximum score of 16.
Data acquisition
Images were acquired from the whole brain using a 1.5 T GE
Signa LX NV/i system (General Electric, Wakashua), incorporating
actively shielded magnetic ﬁeld gradients (maximum amplitude
40 mT/m) and a standard quadrature birdcage head coil. Images
were acquired parallel to the anterior commissureeposterior
commissure (AC-PC) line.
Using a multislice, peripherally gated EPI pulse sequence, each
DTI volume was acquired from 60 contiguous 2.5 mm thick
slices with ﬁeld of view (FOV) of 2403240 mm and matrix size
of 96396, zero-ﬁlled to 1283128, ultimately giving an in-plane
voxel size of 1.87531.875 mm2. The echo time (TE) was 107 ms,
with effective repetition times (TR) of 15 ReR intervals. Seven
images were obtained at each location without diffusion
weighting, with 64 images with a weighting of 1300 s/mm2
applied along directions uniformly distributed in space.21
Cardiac gated DTI data acquisition led to variations in scanning
time in relation to each patient’s pulse rate, and were on average
25 min.
Data preprocessing
Data processing was performed using the ExploreDTI v4.4
software package.22 The DTI data sets were corrected for head
motion and eddy-current-induced geometric distortions. During
this correction procedure, the b-matrix was adjusted for potential
subject motion to ensure correct diffusion tensor estimates.23
The diffusion tensor was then calculated on a voxel-by-voxel
basis using a weighted multivariate linear regression after loga-
rithmic transformation of the signal intensities,24 and tensor
matrix diagonalised to compute the eigenvalues and eigenvectors.
Image analysis
Data from one patient with sporadic ALS were not included in
subsequent analyses owing to poor quality. Fibre tracking was
performed with a standard DTI-based deterministic streamline
ﬁbre tracking method using all brain voxels with FA >0.2 in
a seed region (described below) as a starting-point.25 Streamlines
were propagated using a Euler integration method with a step
size of 0.5 mm as described by Basser et al.25 Streamlines were
stopped when FA was lower than 0.2, or the angle between two
steps was greater than 358. This acts to terminate tract trajec-
tories that do not match natural white-matter pathways of the
brain.26 Diffusion tensor tractography can be used to delineate
ﬁbre pathways by placing multiple ROI functions (SEED, AND
and NOT) on anatomical landmarks. In order to determine the
location of the corticospinal tract, detailed white-matter atlases
were used to identify anatomical structures known to be
associated with it.13 A neurologist experienced with white-
matter-tract anatomy and tractography (MC) assisted with
identiﬁcation of the corticospinal tracts in order to ensure the
accurate dissection of tracts during analysis. Qualitative assess-
ment of images and identiﬁcation of anatomical features were
performed blind to subject status, as was ﬁbre tracking. The
corticospinal tract was primarily identiﬁed using directionally
encoded colour maps27 to indicate the directionality of projection
ﬁbres via colour representations on axial slices (illustrated in
ﬁgure 1A). ROIs were deﬁned in each hemisphere using FA maps
(illustrated in ﬁgure 1B). In the current study, a ‘SEED’ ROI was
placed in the posterior limb of the internal capsule (illustrated in
ﬁgure 1C) and an ‘AND’ ROI on the most caudal aspect of the
cerebral peduncle (illustrated in ﬁgure 1D). The SEED and AND
regions are chosen to be large enough to include all voxels that
might be part of the CST at the relevant levels. Spurious ﬁbres
that were not associated with the corticospinal tract were elim-
inated by rejecting streamlines shorter than 20 mm or greater
than 500 mm in length and also using a ‘NOT’ ROI, with dele-
tion conﬁrmed by a recalculation of tracts. The entire intracranial
portions of the corticospinal tracts of both cerebral hemispheres
(illustrated in ﬁgure 1E) were then separately analysed.
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To provide further measures of diffusion, eigenvalues were
sorted in order of decreasing magnitude (l1>l2>l3). Diffusion
parallel to ﬁbre tract orientation is represented by the principal
eigenvalue, l1, giving a measure of axial diffusivity. Diffusion
eigenvalues perpendicular to the main ﬁbre tract (l2 and l3)
were averaged and are referred to here as radial diffusivity.
Statistical analysis
A one-way repeated-measures ANOVA was applied to examine
group differences in FA, MD, axial and radial diffusivity, with
group as the between-subject factor and diffusion measures as
the repeated measures within-subject factor. Appropriate post
hoc analyses were performed on all signiﬁcant group results.
Correlation analyses were performed between diffusion
measures (FA and MD) and clinical scores (disease duration,
ALSFRS-R, Ashworth Spasticity Scale and UMN burden) for
sporadic ALS and hom D90A patient groups separately using
Pearson’s correlation coefﬁcient. Sensitivity, speciﬁcity and
positive predictive values for mean CST FA were calculated for
the sALS and control groups.
RESULTS
Subject characteristics
Demographic and clinical data for all three groups are given in
table 1. There was no signiﬁcant difference in age between the
three groups (p¼0.62). The homD90A ALS patient group had
a higher proportion of female subjects than sporadic ALS or
controls. There was no signiﬁcant difference in the global
measure of disease severity (ALSFRS-R) between the two patient
groups (p¼0.74). There was no signiﬁcant difference between
Figure 1 MR images and regions of
interest used in the study.
(A) Anatomical structures were located
using directionally encoded colour
maps. These maps were used to
determine the most rostral component
of the internal capsule and the most
caudal aspect of the cerebral peduncle.
(B) Grey-scale fractional anisotropy
images. (C) Example of regions of
interest (ROI) and tract configuration in
3-D. (D) ‘SEED’ ROI on the posterior limb
of the internal capsule. (E) ‘AND’ ROI on
the cerebral peduncle.
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sporadic ALS and homD90A patients in the UMN burden score
(p¼0.08). Data for the Ashworth spasticity scale were unavail-
able for one patient with sporadic ALS. The patient groups
differed on the Ashworth Spasticity Scale with the homD90A
patients more severely affected (p<0.001).
Fractional anisotropy and mean diffusivity
FA and MD results are summarised in table 2 and displayed in
ﬁgure 2. Average values from both CSTs are presented. A one-
way independent ANOVA revealed a signiﬁcant group effect for
measures of FA (p<0.001) but not MD (p<0.06) along the
corticospinal tract. Post hoc tests revealed that FA was signiﬁ-
cantly lower in the CST in patients with sporadic ALS compared
with both homD90A ALS patients (p<0.001) and controls
(p<0.001). There were no differences in FA measures between
homD90A ALS patients and controls. Using average FA values of
the right and left CST gave sensitivity, speciﬁcity and positive
predictive values of 85%, 63% and 72% respectively for
discriminating sALS patients from controls. This is below a level
that would be considered useful clinically.
Radial and axial diffusivity
One-way ANOVA revealed a signiﬁcant effect of group for radial
(p<0.001), but not axial (p¼0.16) diffusivity within the CST.
Therefore, post hoc tests were carried out for radial diffusivity
alone. These revealed that radial diffusivity in the CST was
signiﬁcantly increased in patients with sporadic ALS compared
with both homD90A ALS patients (p¼0.001) and controls
(p<0.001).
Clinicoradiological correlations
Clinicoradiological correlations were examined for the sporadic
ALS and homD90A ALS patient groups separately. There were
no signiﬁcant correlations between disease duration and any of
the diffusion measures in either of the patient groups.
In the sporadic ALS group, a moderate negative correlation
was noted between CST FA and the UMN burden score
(r¼0.49, p¼0.03) and Ashworth Spasticity Scales (r¼0.51,
p¼0.02) as illustrated by ﬁgure 3. However, there were no
correlations between diffusion measures and the global measure
of disease severity (ALSFRS-R), or between MD, radial
diffusivity or axial diffusivity and clinical scores.
In the homD90A ALS group, there were no correlations
between any of the diffusion measures (FA, MD, radial
diffusivity, axial diffusivity) and the clinical scores.
DISCUSSION
In this study, we examined genotype/phenotype interactions in
ALS by quantifying differences in diffusion measures reﬂecting
axonal damage in the intracerebral portion of the CST in familial
and sporadic ALS patients. Despite the smaller size of the
homozygous D90A SOD1 ALS group, the power to detect
between-group differences remains good because of their
homogeneity, as illustrated by ﬁgure 2. FA in the CST was
markedly reduced in patients with sporadic ALS compared with
familial ALS patients homozygous for the D90A SOD1 gene
mutation. HomD90A ALS patients showed no differences to
the control group on any of the diffusion measures. This is
consistent with axonal degeneration within the intracerebral
portion of the CST in sporadic ALS, but with apparent relative
preservation in homD90A ALS patients, despite similar levels of
upper motor neuron dysfunction and overall disability clinically.
In addition, in sporadic ALS patients, reductions in CST FAwere
related to greater ‘bedside’ scores of UMN dysfunction, whereas
in homD90A ALS patients there was no relationship between
clinical UMN dysfunction and any of the intracerebral CST
diffusion measures.
There was disparity in disease duration between the patient
groups, with homD90A ALS patients having a longer disease
duration compared with patients with sporadic ALS. This is
consistent with the natural history of ALS in patients with the
homD90A SOD1 gene mutation, where the disease is slowly
progressive. We do not think that we are simply comparing
rapidly progressing ALS (sporadic ALS) with slowly progressing
cases that are in the early stages (homD90A) because measures
of global (ALSFRS-R) and speciﬁc (‘UMN burden’) clinical
severity are comparable. This implies that we are quantifying
the pathology at a similar point in the disease process.
Patients were included in the study as ‘sporadic ALS’ if they
had no family history of ALS. However, recent genetic studies
Table 1 Demographic and clinical data of control subjects and patient
groups
Control
Sporadic
amyotrophic
lateral sclerosis
Amyotrophic lateral
sclerosis patients
homozygous for
aspartate-to-alanine
mutations in codon 90
N 20 20 7
Gender (male:female) 12:8 14:6 1:6
Age (years) 53616 56611 50611
Site of disease
onset
NA 16 limb 7 limb
4 bulbar
Disease duration
(months)
NA 28618 42647
Amyotrophic lateral
sclerosis functional
rating scale
NA 3866 3767
Ashworth spasticity
score
NA 263 962
Upper motor neuron
burden score
NA 866 962
Table 2 Mean (SD) diffusion measures from the corticospinal tracts in patient groups and controls
Sporadic
amyotrophic
lateral sclerosis
Amyotrophic lateral sclerosis
patients homozygous for
aspartate-to-alanine
mutations in codon 90 Controls Statistics
Diffusion measures
Fractional anisotropy 0.46 (0.03)* 0.53 (0.02) 0.51 (0.04) F¼13.8, p<0.001
Mean diffusivity (103 mm2/s) 0.72 (0.04) 0.70 (0.02) 0.69 (0.03) F¼3.1, p¼0.06
Radial diffusivity (103 mm2/s) 0.52 (0.04)* 0.46 (0.02) 0.47 (0.03) F¼10.0, p<0.001
Axial diffusivity (102 mm2/s) 0.11 (0.05) 0.12 (0.04) 0.11 (0.07) F¼1.9, p¼0.16
*Sporadic amyotrophic lateral sclerosis group different from both the group of amyotrophic lateral sclerosis patients homozygous for
aspartate-to-alanine mutations in codon 90 (p<0.001) and controls (p<0.001).
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have shown that 1e7% of apparently sporadic ALS patients
carry a SOD1 gene mutation and in rare cases may carry TDP43,
Angiogenin, FUS and Dynactin mutations. We did not perform
genetic tests on the patients with apparently sporadic ALS,
recruited into this study. While there is a theoretical possibility
that the sporadic ALS group may have included patients
carrying a gene mutation, it is extremely unlikely that this
would be the rare homD90A SOD1 genotype.
Using diffusion tensor tractography, we have quantiﬁed
differences in involvement of a key cerebral region (CST)
between homD90A and sporadic ALS patients, that were
suggested using whole-brain voxel-based analysis techniques of
structural MRI and DTI. When these groups were both
compared with controls, patients with sporadic ALS showed
more pronounced areas of grey-matter atrophy within motor
and premotor cortices than the familial group.16 FA was
higher in motor and extra-motor regions in homD90A ALS
patients compared with sporadic ALS (in addition to occipito-
temporal and occipito-parietal areas), suggesting preservation of
white-matter structure in these regions.14
To understand more about the possible differences in patho-
logical mechanisms between homD90A ALS and sporadic ALS
groups, we examined individual diffusion components that
determine FA and MD (radial and axial diffusivity). This was
not possible using our previous whole-brain FA voxelwise
group-analysis approach.14 In patients with sporadic ALS,
although there was a marked reduction in FA compared with the
control group, MD was relatively preserved along the CST. This
is a generally consistent ﬁnding in studies using DTI to examine
axonal degeneration within the CST in sporadic ALS.7 28e31
In patients with sporadic ALS, we demonstrated that radial
diffusivity (the degree of diffusion perpendicular to the white-
matter tract) was signiﬁcantly increased compared with
controls, whereas axial diffusivity (the degree of diffusion
parallel to the white-matter tract) did not differ from controls.
The same proﬁle of diffusion values has also been demonstrated
in the corticospinal tract of sporadic ALS patients using an ROI
approach31 and more recently with tractography.32 33 This
suggests that reductions in FA in sporadic ALS are due to
increased diffusivity of water molecules across white-matter
ﬁbres within the CST, rather than impedence of diffusivity along
the tract. This pattern of diffusion values (reduced FA, preserved
MD, increased radial but not axial diffusivity) is proposed to be
highly suggestive of secondary damage to white matter, where
there is anterograde (or Wallerian) axonal degeneration following
a neuronal insult.34 This contrasts with primary damage to
Figure 2 Corticospinal tract fractional
anisotropy (FA), mean diffusivity
(3103 mm2/s), axial
diffusivity (3103 mm2/s) and
radial diffusivity (3103 mm2/s) in
patients with sporadic amyotrophic
lateral sclerosis (sALS), patients
homozygous for aspartate-to-alanine
mutations in codon 90 (D90A) and
control subjects.
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Figure 3 Correlations between
corticospinal tract fractional anisotropy
and upper motor neuron (UMN) burden
score (r¼0.49, p¼0.03) and
Ashworth Spasticity Scale (r¼0.51,
p¼0.02) in the sporadic amyotrophic
lateral sclerosis group.
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white matter, as occurs in strokes or multiple sclerosis, where
there is a global increase in diffusivity of water molecules and
a consistent, more marked increase in MD.34 In sporadic ALS
patients, the proﬁle of diffusion values consistent with Wallerian
degeneration is in keeping with the notion that the predominant
pathological insult in ALS is to cortical neurons. As suggested by
animal models of Wallerian degeneration, it is likely that
demyelination and an increase in isotropic tissue structures such
as gliosis and extracellular matrix must be present in sporadic
ALS patients (in addition to axonal loss) to produce this proﬁle
of diffusion values.35 36
In homD90A ALS patients, all of the diffusion components
within the intracerebral portion of the CSTwere similar to those
of healthy control subjects, despite levels of disability and clin-
ical UMN involvement comparable with the sporadic ALS
patients. The DTI ﬁndings indicate that there may be less
Wallerian degeneration of the intracerebral portion of the CST in
homD90A ALS patients compared with those with sporadic
ALS, in keeping with the notion that there is relative preserva-
tion of the motor cortex in this patient group. A possible
mechanism for the relative sparing of intracerebral motor
regions in homD90A patients might be preservation of the
activity of cortical inhibitory circuits. This is supported by the
relative conservation of cortical inhibition determined neuro-
physiologically in homD90A versus sporadic ALS patients,15 and
the differential reductions in [11-C]-ﬂumazenil cortical binding.37
Similar to this study, in sporadic ALS patients a tight link has
been previously shown between clinical UMN involvement and
CST FA.29 38 39 Although we did not examine the proﬁle of
diffusion measures from the spinal cord in this study, we spec-
ulate that degeneration of the CST within the spinal cord,
perhaps owing to a ‘dying-back’ process from the anterior
horn,40 may instead account for the marked UMN dysfunction
seen clinically in homD90A ALS patients.
In this study, we have quantiﬁed genotypic inﬂuences on the
phenotype in ALS, with relative preservation of the intracerebral
portion of the CST in ALS patients homozygous for the D90A
SOD-1 gene mutation. Further investigation of possible protec-
tive processes within the cerebral cortex in homD90A ALS
patients may provide clues to mechanisms which are responsible
for their prolonged survival. Future studies could beneﬁt from
the higher signal-to-noise ratios and resolution available with
3 T and higher-ﬁeld-strength scanners, as well as multicentre
pooling of such rare groups.
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